Literature DB >> 34125328

Quisinostat mediated autophagy is associated with differentiation in neuroblastoma SK-N-SH cells.

Vamsi Krishna Kommalapati1,2, Dinesh Kumar1,2, Anjana Devi Tangutur3,4.   

Abstract

Neuroblastoma (NB) is the most common childhood cancer that arises from the sympathetic nervous system. NB is characterized by poor prognosis. One of the strategies to control NB is activating the differentiation process in undifferentiated NB cells. Many differentiating agents including 13-cis-retinoic acid (RA) led to disappointing results. In the current study, we investigated the effect of Quisinostat/JNJ-26481585(JNJ) on NB SK-N-SH cells differentiation. The SK-N-SH cell differentiation was observed by morphology and neurite length measurement. The cell cycle arrest was determined by FACS analysis. The relative levels of autophagy marker LC3-II, neuronal markers βIII-tubulin and Eno-2, cell cycle related proteins cyclin D1 and CDK 4 were detected by western blotting. JNJ induces differentiation in SK-N-SH cells, as evident by the morphological features and expression of neuronal markers, βIII-tubulin and Eno-2. Cell cycle arrest at G1 phase was confirmed by a decrease in the expression of cyclin D1 and CDK 4. Furthermore, we also observed that autophagy plays an important role in JNJ induced cell differentiation of SK-N-SH cells. We demonstrated that autophagy is induced upon JNJ treatment and is important for the neuronal differentiation of human SK-N-SH cells.

Entities:  

Keywords:  Autophagy; Differentiation; Neuroblastoma; Quisinostat

Mesh:

Substances:

Year:  2021        PMID: 34125328     DOI: 10.1007/s11033-021-06481-z

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  26 in total

Review 1.  Autophagy: renovation of cells and tissues.

Authors:  Noboru Mizushima; Masaaki Komatsu
Journal:  Cell       Date:  2011-11-11       Impact factor: 41.582

2.  Roles of autophagy and mTOR signaling in neuronal differentiation of mouse neuroblastoma cells.

Authors:  Mei Zeng; Jiang-Ning Zhou
Journal:  Cell Signal       Date:  2008-01-22       Impact factor: 4.315

Review 3.  Autophagy in mammalian development and differentiation.

Authors:  Noboru Mizushima; Beth Levine
Journal:  Nat Cell Biol       Date:  2010-09       Impact factor: 28.824

4.  Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study.

Authors:  Katherine K Matthay; C Patrick Reynolds; Robert C Seeger; Hiroyuki Shimada; E Stanton Adkins; Daphne Haas-Kogan; Robert B Gerbing; Wendy B London; Judith G Villablanca
Journal:  J Clin Oncol       Date:  2009-01-26       Impact factor: 44.544

Review 5.  Development of differentiation modulators and targeted agents for treating neuroblastoma.

Authors:  Zegao Jin; Yang Lu; Yizhe Wu; Jinxin Che; Xiaowu Dong
Journal:  Eur J Med Chem       Date:  2020-09-08       Impact factor: 6.514

6.  Inhibition of JNJ-26481585-mediated autophagy induces apoptosis via ROS activation and mitochondrial membrane potential disruption in neuroblastoma cells.

Authors:  Vamsi Krishna Kommalapati; Dinesh Kumar; Anjana Devi Tangutur
Journal:  Mol Cell Biochem       Date:  2020-03-07       Impact factor: 3.396

Review 7.  Differentiation therapy revisited.

Authors:  Hugues de Thé
Journal:  Nat Rev Cancer       Date:  2017-12-01       Impact factor: 60.716

Review 8.  Treatment for superficial infusion thrombophlebitis of the upper extremity.

Authors:  Marcello Di Nisio; Frank Peinemann; Ettore Porreca; Anne W S Rutjes
Journal:  Cochrane Database Syst Rev       Date:  2015-11-20

Review 9.  Autophagy in the Regulation of Tissue Differentiation and Homeostasis.

Authors:  Cristiana Perrotta; Maria Grazia Cattaneo; Raffaella Molteni; Clara De Palma
Journal:  Front Cell Dev Biol       Date:  2020-12-10

Review 10.  The molecular hallmarks of epigenetic control.

Authors:  C David Allis; Thomas Jenuwein
Journal:  Nat Rev Genet       Date:  2016-06-27       Impact factor: 53.242

View more
  2 in total

Review 1.  The role of protein acetylation in carcinogenesis and targeted drug discovery.

Authors:  Jingru Yang; Cong Song; Xianquan Zhan
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-12       Impact factor: 6.055

2.  Silencing of PFKFB3 protects podocytes against high glucose‑induced injury by inducing autophagy.

Authors:  Zhengming Zhu; Qingsheng Liu; Jianshi Sun; Ziyang Bao; Weiwei Wang
Journal:  Mol Med Rep       Date:  2021-09-07       Impact factor: 2.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.